Montastruc, François
Khosrow-Khavar, Farzin
de Germay, Sibylle
Renoux, Christel
Rousseau, Vanessa
Durrieu, Geneviève
Montastruc, Marion
Rascol, Olivier
Sommet, Agnès
Lapeyre-Mestre, Maryse
Benevent, Justine
Montastruc, Jean-Louis
Article History
Received: 13 April 2018
Accepted: 24 May 2018
First Online: 3 June 2018
Compliance with ethical standards
:
: None, except for Professor Olivier Rascol who was consultant and/or member of advisory boards for AbbVie, Adamas, Acorda, Addex, AlzProtect, Apopharma, Astrazeneca, Bial, Biogen, Britannia, Clevexel, INC Reasearch, Lundbeck, Lupin, Merck, MundiPharma, Neuratris, Neuroderm, Novartis, Oxford Biomedica, Parexel, Pfizer, Prexton Therapeutics, Quintiles, Sanofi, Servier, Sunovion, Takeda, Teva, UCB, XenoPort, and Zambon and received grants from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, and European Commission (FP7, H2020).